Amador Bioscience
Latest round
- Series B
Last raised
- Oct 2021
Total raised
- Undisclosed
Investors
- 6
About Amador Bioscience
Based in Hangzhou, China, and established in 2018, Amador Bioscience is a contract research organization about translational science and clinical pharmacology that provides services such as clinical pharmacology, laboratory testing, clinical project management, and regulatory reporting that meet international standards. The company has a clinical pharmacology, laboratory testing and clinical research team with rich experience in industry research and development services. At present, it has provided many Chinese and American innovative drug R&D companies with professional services on multiple projects from preclinical, clinical development to regulatory declaration, and post-marketing. The company provides clinical pharmacology, laboratory testing, clinical project management, and regulatory reporting that meet international standards. Clinical pharmacology focuses on modeling & simulation of FIH dose selection, data analysis and reporting of preclinical. Laboratory services focus on non-clinical and clinical sample bioanalysis methodology development, validation and sample testing. Clinical trial project management focuses on providing clinical project management for domestic and foreign innovative drug research and development companies. In addition, it can also provides data analysis that meets international standards and generate complete application materials. The company plans to strengthen its clinical pharmacology business, expand global bioanalytical services, and further improve global early clinical development capabilities, and introduce talents. Moreover, the company will acquire Ann Arbor Pharmacometrics Group.
Who invested in Amador Bioscience
6 investors across 2 rounds
See all investors in Amador Bioscience
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Amador Bioscience
Who invested in Amador Bioscience?
Amador Bioscience has 6 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Amador Bioscience raised?
Amador Bioscience has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did Amador Bioscience last raise money?
Amador Bioscience's most recent round on record is a Series B, in Oct 2021.
What does Amador Bioscience do?
Based in Hangzhou, China, and established in 2018, Amador Bioscience is a contract research organization about translational science and clinical pharmacology that provides services such as clinical pharmacology, laboratory testing, clinical project management, and regulatory reporting that meet international standards.
Where is Amador Bioscience headquartered?
Amador Bioscience is headquartered in Hangzhou, China.
Which VCs invest in companies like Amador Bioscience?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Yufu Capital, Hengxu Capital and Riverhead Capital back healthcare companies at Amador Bioscience's stage. Their profiles are linked below.
VCs backing healthcare startups at Series B
Raising like Amador Bioscience? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.